Understanding the Spatial Topology of Artificial Immunological Synapses Assembled in T Cell-Redirecting Strategies: A Major Issue in Cancer Immunotherapy-Reference-Cited by-同舟云学术

Understanding the Spatial Topology of Artificial Immunological Synapses Assembled in T Cell-Redirecting Strategies: A Major Issue in Cancer Immunotherapy

Published:2020-01-10 Issue: Volume:7 Page:
ISSN:2296-634X
Container-title:Frontiers in Cell and Developmental Biology
language:
Short-container-title:Front. Cell Dev. Biol.

Author:

Roda-Navarro Pedro,Álvarez-Vallina Luis

Funder

Ministerio de Economía, Industria y Competitividad, Gobierno de España

Publisher

Frontiers Media SA

Subject

Cell Biology,Developmental Biology

Reference41 articles.

1. Editorial: molecular dynamics at the immunological synapse;Alcover;Front. Immunol.,2016

2. Efficacy and toxicity management of CAR-T-cell immunotherapy: a matter of responsiveness control or tumour-specificity?;Alonso-Camino;Biochem. Soc. Trans.,2016

3. F-actin polymerization and retrograde flow drive sustained PLCγ1 signaling during T cell activation;Babich;J. Cell Biol,2012

4. ma membrane LAT activation precedes vesicular recruitment defining two phases of early T-cell activation;Balagopalan;Nat. Commun,2018

5. Mechanical communication at the immunological synapse;Basu;Trends Cell Biol.,2017

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel FRET‐based Immunological Synapse Biosensor for the Prediction of Chimeric Antigen Receptor‐T Cell Function;Small Methods;2024-09-11

2. Decoupling individual host response and immune cell engager cytotoxic potency;2024-06-25

3. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo;Science Translational Medicine;2024-02-14

4. Actin cytoskeleton remodeling at the cancer cell side of the immunological synapse: good, bad, or both?;Frontiers in Immunology;2023-10-05

5. Bringing cell therapy to tumors: considerations for optimal CAR binder design;Antibody Therapeutics;2023-09-12